{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "8918b843-d602-4b31-9f4b-ce6608bb92f2",
   "metadata": {},
   "source": [
    "# Phase 3: Model Architecture Design and Implementation (The Model Core)\n",
    "\n",
    "That's the core of the problem! Designing the protein encoding and the fusion mechanism are crucial steps for achieving an accurate Drug-Target Interaction (DTI) model.\n",
    "\n",
    "Here is the detailed plan for Phase 3: Model Architecture, covering the protein sequence encoder (CNN/RNN) and the feature fusion mechanism.\n",
    "\n",
    "**1. Protein Sequence Encoding Module (Target Feature Learner)**\n",
    "\n",
    "The goal of this module is to take the numerically encoded amino acid sequence and compress it into a fixed-size, information-rich protein feature vector (VP). 1D Convolutional Neural Networks (CNNs) are highly effective here as they can automatically capture local, sequence-based patterns, which often correspond to functional motifs or potential binding pockets.\n",
    "\n",
    "###### **Step 3.1.1: Input Preparation (Embedding Layer)**\n",
    "\n",
    "- 1. **Input:** The protein sequence, usually zero-padded to a maximum length (Lmax), encoded as a matrix of shape (Lmax, Ncahr_freatures), where Ncahr_freatures is the size of the one-hot or PSSM encoding (e.g., 20 or 21).\n",
    "- **2. Embedding:** Optionally, pass the input through an initial embedding layer to learn dense, low-dimensional vectors for each amino acid, which can improve feature learning compared to sparse one-hot vectors.\n",
    "\n",
    "###### **Step 3.1.2: 1D Convolutional Layers**\n",
    "- **1. Convolution:** Apply multiple 1D Convolutional Layers (Conv1D). Each layer uses filters (kernels) to slide across the sequence, identifying local patterns of amino acids (e.g., small binding motifs, secondary structure elements).\n",
    "    - Kernel Size: Experiment with different kernel sizes (e.g., 3, 5, 7) to capture different length patterns.\n",
    "    - Output Channels (Filters): Use multiple filters (e.g., 32, 64, 128) per layer to learn diverse patterns.\n",
    "- **2.\tActivation:** Follow each convolution layer with a non-linear activation function (e.g., ReLU).\n",
    "- **3.\tPooling:** Use a Max Pooling or Global Max/Average Pooling layer after the convolutions. This down-samples the feature maps and consolidates the local pattern information into a fixed-size vector.\n",
    "\n",
    "###### **Step 3.1.3: Output**\n",
    "The final output is the fixed-size Protein Feature Vector (VD).\n",
    "\n",
    "###### 2. Feature Fusion and Prediction Head\n",
    "\n",
    "The fusion mechanism is the central point where the knowledge of the drug and the protein \n",
    "meet to predict the interaction.\n",
    "\n",
    "###### Step 3.2.1: Drug Feature Vector (VD)\n",
    "- This vector comes from the output of your Graph Neural Network (GNN) module (Phase 2), typically generated by a Global Pooling operation on the atom features.\n",
    "\n",
    "###### Step 3.2.2: Simple Fusion: Concatenation (Baseline)\n",
    "The simplest and most common initial approach is Concatenation (Early Fusion):\n",
    "Vpair = [VD * VP]\n",
    "- The drug vector and protein vector are simply joined to form one long vector Vpair. This vector represents the entire drug-target pair.\n",
    "\n",
    "###### Step 3.2.3: Advanced Fusion: Attention Mechanism (Enhanced Interpretability)\n",
    "For better performance and biological interpretability, use a Co-Attention or Bilinear Interaction module:\n",
    "- Co-Attention: Allows the model to learn where to focus its attention on the drug structure and the protein sequence simultaneously. It essentially computes a weighted summary of the pro-tein features based on the drug features, and vice versa. This can help highlight the specific atoms and residues responsible for the predicted binding.\n",
    "- Bilinear Interaction: Models a more complex, multiplicative interaction, often represented as:\n",
    "Vpair = VTD * W * VP\n",
    "\n",
    "where W is a trainable weight matrix that captures the interaction between drug and target fea-tures.\n",
    "\n",
    "###### Step 3.2.4: Prediction Head (The Classifier)\n",
    "The fused vector Vpair is passed into the final Feed-Forward Network (FNN):\n",
    "- **1.\tDense Layers:** Two or three fully connected layers with ReLU activation.\n",
    "    \n",
    "- **2.\tOutput Layer:** A final fully connected layer with a single output neuron.\n",
    "    \n",
    "- **3.\tActivation:** Use a Sigmoid activation function to output a probability p âˆˆ [0, 1] of interaction (for classification), or a Linear activation to predict the binding affinity value (for regression).\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "2b9e251b-24f6-4e1d-adf4-747fe7b29e75",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
